Table 1.
Characteristic | R group (n = 16) | NR group (n = 8) | P value |
---|---|---|---|
Gender | 1.000 | ||
Male | 10 | 5 | |
Female | 6 | 3 | |
age | 0.362 | ||
<65 | 13 | 5 | |
≥65 | 3 | 3 | |
ECOG | 0.249 | ||
0–1 | 15 | 6 | |
≥2 | 1 | 2 | |
Smoking history | 0.388 | ||
Current or former | 8 | 2 | |
Never | 8 | 6 | |
Antibiotic use | 1.000 | ||
In ≤1month | 3 | 2 | |
No | 13 | 6 | |
Metastasis number | 1.000 | ||
number<2 | 12 | 6 | |
number≥2 | 4 | 2 | |
CNS metastasis | 0.536 | ||
yes | 2 | 0 | |
no | 14 | 8 | |
Liver metastasis | 0.065 | ||
yes | 2 | 0 | |
no | 14 | 8 | |
Lung metastasis | 0.621 | ||
yes | 5 | 1 | |
no | 11 | 7 | |
Bone metastasis | 0.363 | ||
yes | 4 | 4 | |
no | 12 | 4 | |
PD-L1 expression | 0.191 | ||
<1% | 3 | 4 | |
≥1% | 12 | 3 | |
unknown | 1 | 1 | |
TMB | 0.095 | ||
<10m/Mb | 5 | 6 | |
≥10m/Mb | 6 | 0 | |
unknown | 5 | 2 | |
Lymphocyte number | 0.167 | ||
<0.8*109/L | 3 | 4 | |
≥0.8*109/L | 13 | 4 | |
LDH | 1.000 | ||
<250U/L | 11 | 5 | |
≥250U/L | 5 | 3 | |
Treatment lines | 0.741 | ||
1 | 7 | 5 | |
1~2 | 5 | 2 | |
≥3 | 4 | 1 |